title: Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting Illness.
authors.affiliation: Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.
authors.forename: Purav
authors.initials: P
authors.lastname: Mody
authors.affiliation: Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas2Department of Clinical Sciences, UT Southwestern Medical Center, Dallas, Texas.
authors.forename: Oanh Kieu
authors.initials: OK
authors.lastname: Nguyen
mesh_terms: D002318:Cardiovascular Diseases; D003072:Cognition Disorders; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D008297:Male; D009369:Neoplasms; D010166:Palliative Care / Q000379:methods*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors